(Q41750434)

8 October 2017

1 reference

title

Glimepiride. A review of its use in the management of type 2 diabetes mellitus (English)

1 reference

8 October 2017

1 reference

H D Langtry

1

1 reference

8 October 2017

J A Balfour

series ordinal

2

1 reference

8 October 2017

publication date

1 April 1998

1 reference

8 October 2017

1 reference

8 October 2017

volume

55

1 reference

8 October 2017

issue

4

1 reference

8 October 2017

page(s)

563-584

1 reference

Pharmacokinetics and safety of glimepiride at clinically effective doses in diabetic patients with renal impairment

8 October 2017

cites work

1 reference

12 December 2020

Efficacy of insulin and sulfonylurea combination therapy in type II diabetes. A meta-analysis of the randomized placebo-controlled trials

1 reference

12 December 2020

Pharmacokinetic basis for the safety of glimepiride in risk groups of NIDDM patients

1 reference

12 December 2020

Cardiovascular effects of conventional sulfonylureas and glimepiride

1 reference

12 December 2020

Combined therapy with a sulfonylurea plus evening insulin: safe, reliable, and becoming routine

1 reference

12 December 2020

Extrapancreatic effects of sulfonylureas--a comparison between glimepiride and conventional sulfonylureas.

1 reference

12 December 2020

Effects of glimepiride on in vivo insulin action in normal and diabetic rats.

1 reference

12 December 2020

Effects of glimepiride and glibenclamide on insulin and glucagon secretion by the perfused rat pancreas

1 reference

12 December 2020

Effects of glimepiride on insulin and glucagon release from isolated rat pancreas at different glucose concentrations

1 reference

12 December 2020

A dose-response study of glimepiride in patients with NIDDM who have previously received sulfonylurea agents. The Glimepiride Protocol #201 Study Group.

1 reference

12 December 2020

Comparison of efficacy, secondary failure rate, and complications of sulfonylureas

1 reference

12 December 2020

Direct effects of glimepiride on protein expression of cardiac glucose transporters

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of the hydroxymetabolite of glimepiride (Amaryl) after intravenous administration

1 reference

12 December 2020

Sulfonylureas in NIDDM.

1 reference

12 December 2020

Absolute bioavailability of glimepiride (Amaryl) after oral administration

1 reference

12 December 2020

Guidelines for good practice in the diagnosis and treatment of non-insulin-dependent diabetes mellitus. Report of a joint working party of the British Diabetic Association, the Research Unit of the Royal College of Physicians, and the Royal college

1 reference

12 December 2020

Antagonism of eicosanoid-induced contraction of rat aorta by sulphonylureas

1 reference

12 December 2020

Clinical evaluation of glimepiride versus glyburide in NIDDM in a double-blind comparative study. Glimepiride/Glyburide Research Group.

1 reference

12 December 2020

Effect of glimepiride (HOE 490) on insulin receptors of skeletal muscles from genetically diabetic KK-Ay mouse

1 reference

12 December 2020

Stimulation of glucose utilization in 3T3 adipocytes and rat diaphragm in vitro by the sulphonylureas, glimepiride and glibenclamide, is correlated with modulations of the cAMP regulatory cascade.

1 reference

12 December 2020

Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

1 reference

12 December 2020

Direct stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulfonylurea glimepiride

1 reference

12 December 2020

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at adipocytes

1 reference

12 December 2020

Short-term comparison of once- versus twice-daily administration of glimepiride in patients with non-insulin-dependent diabetes mellitus.

1 reference

12 December 2020

The sulfonylurea drug, glimepiride, stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro

1 reference

12 December 2020

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. II. Photoaffinity labeling of a 65 kDa protein by [3H]glimepiride

1 reference

12 December 2020

An overview of the safety and tolerance of glimepiride

1 reference

12 December 2020

Dose relationship of stimulated insulin production following intravenous application of glimepiride in healthy man

1 reference

12 December 2020

Long-term treatment of type 2 diabetic patients with the new oral antidiabetic agent glimepiride (Amaryl): a double-blind comparison with glibenclamide

1 reference

12 December 2020

Dose linearity assessment of glimepiride (Amaryl) tablets in healthy volunteers

1 reference

12 December 2020

Influence of oral sulfonylurea agents on hepatic glucose uptake.

1 reference

12 December 2020

Interaction of sulphonylurea derivatives with vascular ATP-sensitive potassium channels in humans

1 reference

12 December 2020

Simultaneous determination of the sulphonylurea glimepiride and its metabolites in human serum and urine by high-performance liquid chromatography after pre-column derivatization

1 reference

12 December 2020

Characterization of the molecular mode of action of the sulfonylurea, glimepiride, at beta-cells

1 reference

12 December 2020

Porin proteins in mitochondria from rat pancreatic islet cells and white adipocytes: identification and regulation of hexokinase binding by the sulfonylurea glimepiride.

1 reference

12 December 2020

Role of sulfonylureas in non-insulin-dependent diabetes mellitus: Part II--"The cons".

1 reference

12 December 2020

Cationic and Secretory Effects of Glimepiride and Glibenclamide in Perifused Rat Islets

1 reference

12 December 2020

Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.

1 reference

12 December 2020

The effects of acute exercise on metabolic control in type II diabetic patients treated with glimepiride or glibenclamide

1 reference

12 December 2020

Worldwide experience of metformin as an effective glucose-lowering agent: a meta-analysis

1 reference

12 December 2020

Glimepiride, a new once-daily sulfonylurea. A double-blind placebo-controlled study of NIDDM patients. Glimepiride Study Group.

1 reference

12 December 2020

Inhibition of K+ channels and stimulation of insulin secretion by the sulfonylurea, glimepiride, in relation to its membrane binding in pancreatic islets

1 reference

12 December 2020

Effect of glimepiride on the electrical activity of isolated rabbit heart muscle

1 reference

12 December 2020

Sex difference in pharmacokinetics of the novel sulfonylurea antidiabetic glimepiride in rats

1 reference

12 December 2020

Differential interaction of glimepiride and glibenclamide with the beta-cell sulfonylurea receptor. I. Binding characteristics

1 reference

12 December 2020

The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus

1 reference

12 December 2020

10.2165/00003495-199855040-00007

Identifiers

DOI

1 reference

Dimensions Publication ID

8 October 2017

1014755969

0 references

1 reference